SNK-001

N/A

Report date: 2025/01/26 16:59:24

Base Information

Drug NameSNK-001
Drug Alias Nameanti-TIGIT monoclonal antibody (SynerK)TIGIT checkpoint inhibitor (SynerK)SNK-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionT cell immunoglobulin and ITIM domains inhibitors
TargetsT cell immunoglobulin and ITIM domains
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSynerK Inc
China Registration ClassN/A

Develop Information

Active CompaniesSynerK Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A